Open AccessHepatitis C virus burden: Treating and educating people without prejudice
Author(s) -
Elettra Merola,
Elisa Menotti,
Giovanna Branz,
Andrea Michielan,
Sonia Seligmann,
Annora Ratti,
F. Agugiaro,
Luisa Moser,
G Vettori,
Anna Franceschini,
William Mantovani,
Riccardo Pertile,
G. De Pretis,
Cecilia Pravadelli
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i7.1495
Subject(s) - medicine , hepatitis c , hepatitis c virus , substance abuse , sofosbuvir , psychiatry , virus , immunology , ribavirin
Hepatitis C virus (HCV) infection has a worldwide incidence of 1.1%. In Italy, 60% of people who inject drugs (PWIDs) and are receiving assistance for substance use disorder are infected with HCV. However, this subset of patients has extremely limited access to care due to multiple factors, including alcohol abuse, psychological comorbidities, and homeless status.